Targeting PI3K/mTOR Signaling in Cancer

DOI: 10.3389/fonc.2014.00084

Keywords: Akt, cancer, clinical trials, mTOR, phosphoinositide 3-kinase

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text